These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6128958)

  • 21. Regulation of activity of purified guanylate cyclase from liver that is unresponsive to nitric oxide.
    Tsai SC; Adamik R; Manganiello VC; Vaughan M
    Biochem J; 1983 Dec; 215(3):447-55. PubMed ID: 6140917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of thiols, sugars, and proteins on nitric oxide activation of guanylate cyclase.
    Braughler JM; Mittal CK; Murad F
    J Biol Chem; 1979 Dec; 254(24):12450-4. PubMed ID: 40996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble guanylate cyclase activation by nitric oxide and its reversal. Involvement of sulfhydryl group oxidation and reduction.
    Braughler JM
    Biochem Pharmacol; 1983 Mar; 32(5):811-8. PubMed ID: 6132608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heme-dependent activation of soluble guanylate cyclase by nitric oxide: regulation of enzyme activity by porphyrins and metalloporphyrins.
    Ignarro LJ
    Semin Hematol; 1989 Jan; 26(1):63-76. PubMed ID: 2564216
    [No Abstract]   [Full Text] [Related]  

  • 25. Electron spin resonance study of the role of nitrosyl-heme in the activation of guanylate cyclase by nitrosoguanidine and related agonists.
    DeRubertis FR; Craven PA; Pratt DW
    Biochem Biophys Res Commun; 1978 Jul; 83(1):158-67. PubMed ID: 29621
    [No Abstract]   [Full Text] [Related]  

  • 26. Partial purification and characterization of particulate guanylate cyclase from rat liver after solubilization with trypsin.
    Waldman SA; Lewicki JA; Brandwein HJ; Murad F
    J Cyclic Nucleotide Res; 1982; 8(6):359-70. PubMed ID: 6136535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guanylate cyclase from bovine lung. Evidence that enzyme activation by phenylhydrazine is mediated by iron-phenyl hemoprotein complexes.
    Ignarro LJ; Wood KS; Ballot B; Wolin MS
    J Biol Chem; 1984 May; 259(9):5923-31. PubMed ID: 6143758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase.
    Wedel B; Humbert P; Harteneck C; Foerster J; Malkewitz J; Böhme E; Schultz G; Koesling D
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2592-6. PubMed ID: 7908439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
    Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of alpha 1 and beta 1 subunits.
    Foerster J; Harteneck C; Malkewitz J; Schultz G; Koesling D
    Eur J Biochem; 1996 Sep; 240(2):380-6. PubMed ID: 8841402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residues stabilizing the heme moiety of the nitric oxide sensor soluble guanylate cyclase.
    Schmidt PM; Rothkegel C; Wunder F; Schröder H; Stasch JP
    Eur J Pharmacol; 2005 Apr; 513(1-2):67-74. PubMed ID: 15878710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor binding assay for nitric oxide- and heme-independent activators of soluble guanylate cyclase.
    Schmidt P; Schramm M; Schröder H; Stasch JP
    Anal Biochem; 2003 Mar; 314(1):162-5. PubMed ID: 12633618
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of nitric oxide-dependent activation of soluble guanylyl cyclase by the antimalarial drug, artemisinin.
    Severina IS; Pyatakova NV; Bussygina OG; Mikhailitsyn FS; Khropov YV
    Eur J Pharmacol; 2002 Mar; 438(1-2):69-73. PubMed ID: 11906712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of intestinal mucosa guanylate cyclase by hemin, heme and protoporphyrin IX.
    elDeib MM; Parker CD; White AA
    Biochim Biophys Acta; 1987 Apr; 928(1):83-91. PubMed ID: 2881583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of YC-1-induced activation of soluble guanylyl cyclase.
    Friebe A; Koesling D
    Mol Pharmacol; 1998 Jan; 53(1):123-7. PubMed ID: 9443939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: a widespread signal transduction mechanism.
    Ignarro LJ
    Biochem Soc Trans; 1992 May; 20(2):465-9. PubMed ID: 1356858
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanisms involved in the blunted nitric oxide-cGMP pathway in hypertensive TGR(mREN2)27 rats.
    Jacke K; Witte K; Lemmer B
    Eur J Pharmacol; 2001 Mar; 415(1):27-30. PubMed ID: 11245848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portal pressure regulation following Kupffer cell activation: control of prostaglandin production by heme oxygenases.
    Steib CJ; Gmelin L; Bilzer M; Göke B; Gerbes AL
    Digestion; 2013; 87(2):102-9. PubMed ID: 23327898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Soluble platelet guanylate cyclase: significance of heme in regulating enzymatic activity and the role of the enzyme in platelet aggregation].
    Severina IS
    Biokhimiia; 1994 Mar; 59(3):325-39. PubMed ID: 7910045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states.
    Stone JR; Marletta MA
    Biochemistry; 1994 May; 33(18):5636-40. PubMed ID: 7910035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.